Resultados: 105

    Vacunas para la COVID-19: capacidad de producción y distribución e implicaciones económicas y políticas. Síntesis rápida.

    A pesar de los 58.5 millones de casos notificados hasta ahora en el mundo, la mayor parte de la población sigue siendo susceptible a la infección, con un importante número de estudios de seroprevalencia reportando un bajo porcentaje de anticuerpos contra el SARSCoV-2, en un rango entre 1.0% y 10.8% (1...

    Intervenciones para la salud mental de estudiantes universitarios durante la pandemia por COVID-19. Síntesis rápida.

    En esta síntesis se consideran las siguientes cuatro acciones concretas: 1. Lineamientos generales en salud mental de universitarios. 2. Promoción y prevención en salud mental. 3. Atención de síntomas mentales. 4. Adaptaciones pedagógicas con énfasis en salud mental. En general, se encontró que l...

    Medidas y adaptaciones para la reapertura segura de escuelas y colegios durante la pandemia por COVID-19. Síntesis rápida

    En esta síntesis se consideran cuatro elementos que se abordaran de manera independiente: 1. La transmisibilidad y gravedad de la infección por SARS-CoV-2 en los niños, niñas y adolescentes. 2. Medidas y adaptaciones para un retorno seguro a las aulas durante la pandemia. 3. Comunicación efectiva co...

    Vacunas para la COVID-19: evidencia sobre seguridad, inmunogenicidad y eficacia. Síntesis rápida

    El fuerte impacto de la enfermedad COVID-19 en la salud, las relaciones sociales y la economía del orbe, presiona el desarrollo de una vacuna efectiva y segura. Sin embargo, la urgencia y premura en el desarrollo de los ensayos clínicos, la reducción ostensible del tiempo de estudio de las vacunas can...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 25 March 2021

    The urgent need for evidence on measures to respond to the COVID-19 pandemic had led to a rapid escalation in numbers of studies testing potential therapeutic options. The vast amount of data generated by these studies must be interpreted quickly so that physicians have the information to make optimal tr...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 29 January 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. This new information must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines m...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 13 January 2021

    This is the fourteenth edition of this database of evidence on potential therapeutic options for COVID-19, in which 68 therapeutic options are examined. This information will help investigators, policy makers, and prescribers navigate the flood of relevant data to ensure that management of COVID-19, at b...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 18 December 2020

    This is the thirteenth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined....

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 30 November 2020

    This is the twelfth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined. Th...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 13 November 2020

    This is the twelfth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined. Th...